CANF analyst estimates
Can-Fite BioPharma (CANF) analyst ratings, the average price target and its range, and every firm's latest call.
- 2 firms rate CANF: 2 buy, 0 hold, 0 sell.
- The average price target is $8.00 from None analysts, from $8.00 to $8.00.
CANF analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Jul 2, 2026 | H.C. Wainwright | Can-Fite BioPharma (CANF) PT Raised to $8 at H.C. WainwrightMember Login | $8.00 |
| May 12, 2026 | H.C. Wainwright | Can-Fite BioPharma target adjusted to $5 from $2.50 at H.C. Wainwright | $5.00 |
| Apr 15, 2025 | Industrial Alliance Securities | Can-Fite price target lowered to $4.50 from $12 at Alliance Global Partners | $4.50 |
| Jul 17, 2024 | EF Hutton | Can-Fite BioPharma initiated with a Buy at EF Hutton | $10.00 |